Lululemon, Broadcom And 3 Stocks To Watch Heading Into Friday

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Johnson Outdoors Inc. (NASDAQ:JOUT) to report quarterly earnings at $0.37 per share on revenue of $168.57 million before the opening bell. Johnson Outdoors shares gained 1.9% to $58.50 in after-hours trading.
  • Lululemon Athletica Inc (NASDAQ:LULU) posted upbeat results for its third quarter, but issued weak holiday-quarter guidance. Lululemon shares dropped 7.5% to $346.40 in the after-hours trading session.
  • Broadcom Inc. (NASDAQ:AVGO) reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share. Broadcom shares gained 3.2% to $548.05 in the after-hours trading session.

Check out our premarket coverage here

  • DocuSign Inc (NASDAQ:DOCU) reported better-than-expected financial results for its third quarter and issued strong guidance. DocuSign shares surged 10.5% to $48.35 in the after-hours trading session.
  • Analysts expect Li Auto Inc. (NASDAQ:LI) to post a quarterly loss at $0.15 per share on revenue of $1.40 billion before the opening bell. Li Auto shares rose 1.9% to $24.55 in after-hours trading.

Also check out this TechTarget, AST SpaceMobile Are Among Oversold Communication Services Stocks: Are They Worth A Look? .

Total
0
Shares
Related Posts
Read More

Novartis Presents New Long-Term Leqvio Data Demonstrating Consistent Efficacy And Safety Beyond Six Years

Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy, provides consistent low-density lipoprotein cholesterol (LDL-–C) reduction beyond six years of treatment1   Eight in ten patients achieved target LDL-C threshold**, in line with previously reported Phase III data1-3  

NVS